SHIRLEY DINGWELL: Open Payments
NPI 1346427853 · WEST HEMPSTEAD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,680 in 70 payments from 8 companies in 2025. Trend: 2023 $1,475 · 2024 $2,336 · 2025 $1,680
Food & beverage: $1,568Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 24 | $538 |
| Teva Pharmaceuticals USA, Inc. | 17 | $434 |
| Lundbeck LLC | 14 | $237 |
| Otsuka America Pharmaceutical, Inc. | 9 | $232 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| Janssen Pharmaceuticals, Inc | 3 | $74 |
| Alkermes, Inc. | 1 | $23 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
Products named: INGREZZA, REXULTI, UZEDY, AUSTEDO XR, COBENFY, SPRAVATO, ABILIFY MAINTENA, ARISTADA.
Industry payments across NY — which companies pay providers there.
